Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma
Open Access
- 8 March 2012
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 20 (2) , 143-150
Abstract
Medulloblastoma is a heterogeneous diffuse neoplasm that can be highly disseminated, and is the most common malignant childhood brain tumor. Although multimodal treatments have improved survival rates for patients with medulloblastoma, these tumors are associated with high morbidity and mortality. New treatment strategies are urgently needed to improve cure rates and, importantly, to spare normal brain tissue from neurotoxicity and patients from life-long cognitive and functional deficits associated with current therapies. In numerous preclinical brain tumor models, neural stem cells (NSCs) have shown great promise as delivery vehicles for therapeutic genes. Here, we have used an established, genetically modified human NSC line (HB1.F3.CD) to deliver carboxylesterase (CE) to cerebellar tumor foci and locally activate the prodrug camptothecin-11 (CPT-11) (Irinotecan) to the potent topoisomerase I inhibitor SN-38. HB1.F3.CD NSC tumor tropism, intratumoral distribution and therapeutic efficacy were investigated in clinically relevant experimental models. Magnetic resonance imaging was used for in vivo tracking of iron nanoparticle-labeled NSCs, and to assess the therapeutic efficacy of CE-expressing HB1.F3.CD cells. As compared with controls, a significant decrease in tumor growth rate was seen in mice that received both NSCs and CPT-11 as their treatment regimen. Thus, this study provides proof-of-concept for NSC-mediated CE/CPT-11 treatment of medulloblastoma, and serves as a foundation for further studies toward potential clinical application.Keywords
This publication has 39 references indexed in Scilit:
- Development and cancer of the cerebellumTrends in Neurosciences, 2011
- Cerebellum2011
- Subtypes of medulloblastoma have distinct developmental originsNature, 2010
- Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic AntibodiesPLOS ONE, 2009
- Iron Labeling and Pre-Clinical MRI Visualization of Therapeutic Human Neural Stem Cells in a Murine Glioma ModelPLOS ONE, 2009
- Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of MedulloblastomaCancer Cell, 2009
- MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticlesMagnetic Resonance in Medicine, 2008
- Detection of migration of locally implanted AC133 + stem cells by cellular magnetic resonance imaging with histological findingsThe FASEB Journal, 2008
- Development of a Tumor-Selective Approach to Treat Metastatic CancerPLOS ONE, 2006
- Magnetic Resonance Imaging and Confocal Microscopy Studies of Magnetically Labeled Endothelial Progenitor Cells Trafficking to Sites of Tumor AngiogenesisStem Cells, 2005